Evolgene Genomics is a biotechnology by-productincoming CIC NanoDAY Donostia originating from the research group. Established in 2018, this limited company, ancestral sequence reconstruction (ASR) to produce enzymes with extraordinary properties using ancestral cellulases and xylanases. This company from Gipuzkoa has developed a new process to produce cellulose nanocrystalsA biomaterial with exceptional properties derived from different cellulose sources, allowing it to be used in a variety of industrial applications. In addition, the production process is carried out in mild conditions and dangerous chemicals are not used.
strategy nanoDAY, R&D Center It is a private non-profit association sponsored by of Donostia. Basque governmentSince its establishment in 2006, it has received various funds from local governments, industry and the European Union. The overall management of the Center is currently in the hands of an executive Board consisting of all partners. cutting-edge research in nanoscience and nanotechnologyto promote high-level training for researchers and to promote cooperation between representatives of the Basque network of science, technology and innovation, and between these representatives and industry.
Qube Pharma (Iruñea-Pamplona)
Qubepharma Group is a drug group It was established in 2007 and consists of four companies specializing in various fields of the pharmaceutical industry: geyserpharma, Pharmaceutical Innovation, Lozy’s Y Sekhmet Pharmaceuticals, in addition to various investment companies. Qube Group, research, development and production of value-added products International markets such as niche generics, OTC products and CE Marked medical devices. Based in Pamplona, Geiserpharma was founded in 2008 and development and commercialization of innovative pharmaceutical products. Lozy’s own 4,000 square meters factory Built in 2015 and equipped with the latest technologies, in the town of Lekaroz, in the north of the regional community development, production and packaging of medicalized sugars.
Located in 45 countries, the company already has an ambitious international expansion plan that drives them to pursue commercial research. Latin Americaespecially in countries like Mexico, Colombia and Chile and expect to operate soon Pacific Asia. Likewise, the group has an investment activity through a fund that invests in emerging companies in the pharmaceutical sector with a high innovation component. And this innovation use of the latest technologies fixed in the activities of companies, in their development or in the form of new release systems. QUBE groupThis was also reflected in the realization of co-creation projects with companies from other sectors.
Biotechnology Institute / Biotechnology Institute (BTI), biomedical researchwas founded in 1999 in Vitoria-Gasteiz by Doctor Eduardo Anitua, a doctor from Vitoria, the current President and Scientific Director of the company. Today BTI is one of the world’s leading companies. implantology and oral rehabilitationas well as an international scientific reference application of regenerative treatments in different fields in the field of medicine, from the field of oral surgery to specialties such as traumatology, dermatology, ophthalmology, sports medicine, cardiovascular surgery, aesthetic medicine and reproductive medicine. Complementarily, the company has expanded its work into new areas of research related to sleep apnea and snoring.
BTI has managed to build a great reputation and has subsidiaries in the USA, Canada, Mexico, Germany, UK, France, Italy and Portugal. It is defined as an innovative company whose activities are based on the union of applied research and professionals. A study developed by 350 people 55 of which are researchers and a benchmark in the industry. R&D laboratory Located in Alto de Armentia AseBio report 2020, which evaluates the developments in biotechnology at the state level. In the said ranking, BTI is ahead of pharmaceutical companies such as the following. Janssen anyone pharmacist, heroes for their vaccines. Also, Anitua’s discoveries in science regenerative medicine It ranks first in the Spanish State ranking prepared by the prestigious. standard universityand 62nd in the world rankings.
histocell a biopharmaceutical based pharmaceutical and health product development for regenerative medicine and cell therapy. Belonging to the NorayBio group, this company has thirty highly specialized employees and manufacturing facilities authorized by the Spanish Pharmaceutical Association.
The Larrabetzu plant is dedicated to the production of sanitary products. regenerative medicine Such as Reoxcare dressings for hard-to-heal wounds marketed under different distribution agreements in Europe, America, Asia and the East Osakidetza Among its customers- and dermocosmetic products Wharton Gel Complex and Histoessence. This line complements drug research and development activities. cellular therapybased on stem cells performed at the company’s facilities Bizkaia Science and Technology Parkat Derio.
business group NorayBio He was born in 2006 with the aim. Incorporating innovative Basque biotechnology companies with an open international business. Founded by entrepreneurs Julio Font and Marta Acilu, the group now includes three companies in the field of bioscience, located in the Bizkaia Science and Technology Park: Noray Bioinformatics, Histocell and ArtinVet.